Coverage of Global Pharma Industry News
The US Food and Drug Administration (FDA) has approved a weekly once dosing option for Amgen blood cancer drug Kyprolis
Continue reading
Janssen Pharmaceutical Companies of Johnson & Johnson has secured marketing authorization for its monoclonal antibody Darzalex (daratumumab) from the European
Continue reading
Amgen seeks FDA approval for infliximab biosimilar ABP 710
Incyte, Innovent announce collaboration for three cancer drugs in China
Japanese pharma company Astellas acquires Potenza Therapeutics
Amgen scores pediatric FDA approval for Nplate in immune thrombocytopenia
Fresenius Kabi launches Omegaven in US for pediatric patients with PNAC
Millendo Therapeutics wraps up merger with OvaScience
Novartis breast cancer drug Kisqali plus endocrine therapy extends PFS
Mirum Pharmaceuticals raises $120m to advance Maralixibat into phase 3
Novartis bags Gilenya EC approval for multiple sclerosis in young patients
Pfizer, AbbVie resolve IP matters for adalimumab biosimilar
Business News Today
